JP2023543254A - ピリド[4,3-b]インドール誘導体およびその医薬としての使用 - Google Patents

ピリド[4,3-b]インドール誘導体およびその医薬としての使用 Download PDF

Info

Publication number
JP2023543254A
JP2023543254A JP2023519165A JP2023519165A JP2023543254A JP 2023543254 A JP2023543254 A JP 2023543254A JP 2023519165 A JP2023519165 A JP 2023519165A JP 2023519165 A JP2023519165 A JP 2023519165A JP 2023543254 A JP2023543254 A JP 2023543254A
Authority
JP
Japan
Prior art keywords
substituted
compound according
alkyl
unsubstituted
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023519165A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543254A5 (cg-RX-API-DMAC7.html
Inventor
フェーダー,リー
バーチ,ジェイソン
サン-オンジュ,ミゲル
ドリッチ,ステファン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventus Therapeutics US Inc
Original Assignee
Ventus Therapeutics US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventus Therapeutics US Inc filed Critical Ventus Therapeutics US Inc
Publication of JP2023543254A publication Critical patent/JP2023543254A/ja
Publication of JP2023543254A5 publication Critical patent/JP2023543254A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2023519165A 2020-09-24 2021-09-23 ピリド[4,3-b]インドール誘導体およびその医薬としての使用 Pending JP2023543254A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063082695P 2020-09-24 2020-09-24
US63/082,695 2020-09-24
PCT/US2021/051670 WO2022066851A1 (en) 2020-09-24 2021-09-23 PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

Publications (2)

Publication Number Publication Date
JP2023543254A true JP2023543254A (ja) 2023-10-13
JP2023543254A5 JP2023543254A5 (cg-RX-API-DMAC7.html) 2024-10-01

Family

ID=80846865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519165A Pending JP2023543254A (ja) 2020-09-24 2021-09-23 ピリド[4,3-b]インドール誘導体およびその医薬としての使用

Country Status (7)

Country Link
US (1) US20240018138A1 (cg-RX-API-DMAC7.html)
EP (1) EP4216940A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023543254A (cg-RX-API-DMAC7.html)
CN (1) CN116209442A (cg-RX-API-DMAC7.html)
AU (1) AU2021349249A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196153A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022066851A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230124665A (ko) 2020-12-22 2023-08-25 노파르티스 아게 Cgas 관련 병태의 치료에 유용한 인돌 유도체
WO2023183275A1 (en) * 2022-03-22 2023-09-28 Ventus Therapeutics U.S., Inc. Hexahydropyrido[4,3-b]indolyl ketone derivatives useful as cgas modulators
CN121248633A (zh) * 2022-11-09 2026-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的环状苯并咪唑衍生物
CN120769854A (zh) * 2022-12-21 2025-10-10 伊莱利利公司 氮杂䓬并[4,5-B]吲哚酮cGAS抑制剂
AR133584A1 (es) 2023-08-18 2025-10-15 Univ Leuven Kath Nuevos compuestos
CN119490508A (zh) * 2023-08-21 2025-02-21 上海交通大学 一类螺环四氢-γ-咔啉衍生物的制备方法以及应用
WO2025218659A1 (en) * 2024-04-16 2025-10-23 Insilico Medicine Ip Limited Novel compounds as cyclic gmp-amp synthase inhibitor and uses thereof
WO2026026969A1 (zh) * 2024-08-01 2026-02-05 杭州英创医药科技有限公司 作为cGAS抑制剂的化合物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012525431A (ja) * 2009-04-29 2012-10-22 メディベイション テクノロジーズ, インコーポレイテッド ピリド[4,3−b]インドールおよびその使用方法
WO2019153002A1 (en) * 2018-02-05 2019-08-08 Lama Lodoe 2,3,4,5-tetrahydro-1h-pyrido[4, 3-b]indole inhibitors of cgas for treating autoinflammatory diseases
JP2019521982A (ja) * 2016-06-16 2019-08-08 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ヘテロアリールエストロゲン受容体モジュレーター及びその使用
WO2020142729A1 (en) * 2019-01-04 2020-07-09 BellBrook Labs Inhibitors of cgas activity as therapeutic agents
WO2020186027A1 (en) * 2019-03-13 2020-09-17 Daisuke Tomita Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021506862A (ja) * 2017-12-19 2021-02-22 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Tlr7/8アンタゴニストおよびそれらの使用

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012525431A (ja) * 2009-04-29 2012-10-22 メディベイション テクノロジーズ, インコーポレイテッド ピリド[4,3−b]インドールおよびその使用方法
JP2019521982A (ja) * 2016-06-16 2019-08-08 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ヘテロアリールエストロゲン受容体モジュレーター及びその使用
WO2019153002A1 (en) * 2018-02-05 2019-08-08 Lama Lodoe 2,3,4,5-tetrahydro-1h-pyrido[4, 3-b]indole inhibitors of cgas for treating autoinflammatory diseases
WO2020142729A1 (en) * 2019-01-04 2020-07-09 BellBrook Labs Inhibitors of cgas activity as therapeutic agents
WO2020186027A1 (en) * 2019-03-13 2020-09-17 Daisuke Tomita Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis

Also Published As

Publication number Publication date
US20240018138A1 (en) 2024-01-18
WO2022066851A1 (en) 2022-03-31
AU2021349249A1 (en) 2023-04-13
EP4216940A1 (en) 2023-08-02
CA3196153A1 (en) 2022-03-31
EP4216940A4 (en) 2025-01-01
CN116209442A (zh) 2023-06-02

Similar Documents

Publication Publication Date Title
EP4216940A1 (en) Pyrido[4,3-b]indole derivatives and their use as pharmaceuticals
US20090105124A1 (en) Heterocyclic modulators of tgr5
JP2018514518A (ja) インドールアミンとしての新規5又は8−置換イミダゾ[1,5−a]ピリジン類、及び/又はトリプトファン2,3−ジオキシゲナーゼ
CN1143080A (zh) 7-二环取代的-3-喹喏酮羧酸衍生物的制备方法
JP2023508097A (ja) タンパク質分解剤化合物の製造方法及び使用
JPS6388182A (ja) イミダゾピリジン誘導体及び医薬組成物
CA3120514A1 (en) Cyclic ureas
JP7561285B2 (ja) 複素環置換の縮合γ-カルボリン誘導体、その製造方法、中間体及び使用
JP7538803B6 (ja) イミダゾキノリンアミン誘導体、医薬組成物、その使用
CN120659784A (zh) 作为c-Kit激酶抑制剂的化合物和组合物
JP7018944B2 (ja) PDE2阻害剤としての[1,2,4]トリアゾロ[1,5-a]ピリミジン化合物
CN114641472A (zh) 用于治疗疾病的双亮氨酸拉链(dlk)激酶的双环[1.1.1]戊烷抑制剂
CN114667289B (zh) 杂芳基血浆激肽释放酶抑制剂
US11858938B2 (en) Imidazo-fused heterocycles and uses thereof
JP2673937B2 (ja) 5−アミノ−8−メチル−7−ピロリジニルキノリン−3−カルボン酸誘導体
RS55201B1 (sr) Antimalarijski agensi
JP2018531993A (ja) Alkおよびsrpk阻害剤ならびに使用方法
EP2742044A1 (en) Antibacterial homopiperidinyl substituted 3,4 dihydro 1h [1,8]naphthyridinones
JP2025535017A (ja) Iapの阻害剤として有用な化合物及び組成物
JP2026053339A (ja) Ahrアゴニスト
CN115066423B (zh) Pd-l1拮抗剂化合物
JPH0559914B2 (cg-RX-API-DMAC7.html)
JP2022527279A (ja) キノリン誘導体及び癌の治療のためのその使用
HK40093069A (en) Pyrido[4,3-b]indole derivatives and their use as pharmaceuticals
KR20240148344A (ko) 피라졸로피리미딘, 이를 포함하는 조성물, 및 이의 용도

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240919

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240919

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251007

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251007

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260331